Page last updated: 2024-09-04

docetaxel anhydrous and Hyperglycemia

docetaxel anhydrous has been researched along with Hyperglycemia in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	5 (71.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahl, A; Biernacka, KM; Gillatt, D; Holly, JM; Perks, CM; Persad, RA; Uzoh, CC; Zeng, L	1
Kang, RY; Kim, HS; Kim, KS; Lee, BK; Lee, JY; Lee, SH; Lee, YJ; Suh, SY; Yoo, KE	1
Cheng, S; Cheon, P; Chow, E; Chow, R; DeAngelis, C; Emmenegger, U; Giotis, A; Lowe, J; McDonald, R; Pasetka, M; Pulenzas, N; Rowbottom, L; Stinson, J; Thavarajah, N	1
Bahl, A; Biernacka, KM; Gillatt, D; Holly, JM; Perks, CM; Persad, RA	1
Beer, TM; Blanke, CD; Lopez, C; Mori, M; Stone, M; Todd, K	1
Astras, G; Hickish, T; Hickish, TF; Kerr, D; Penfold, S; Purandare, L; Thomas, P	1
Brunello, A; Extermann, M; Kapoor, R	1

Trials

1 trial(s) available for docetaxel anhydrous and Hyperglycemia

Article	Year
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer. Investigational new drugs, 2009, Volume: 27, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Calcitriol; Calcium Channel Agonists; Calcium, Dietary; Disease Progression; Docetaxel; Drug Therapy, Combination; Fatigue; Female; Humans; Hyperglycemia; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2009

Article

Year

Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer.

Investigational new drugs, 2009, Volume: 27, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Calcitriol; Calcium Channel Agonists; Calcium, Dietary; Disease Progression; Docetaxel; Drug Therapy, Combination; Fatigue; Female; Humans; Hyperglycemia; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome

2009

Other Studies

6 other study(ies) available for docetaxel anhydrous and Hyperglycemia

Article	Year
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. Endocrine-related cancer, 2013, Volume: 20, Issue:5 Topics: Acetylation; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hyperglycemia; Insulin-Like Growth Factor Binding Protein 2; Male; Naphthols; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Sirtuin 1; Sirtuin 2; Taxoids	2013
Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Humans; Hyperglycemia; Infections; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Taxoids; Young Adult	2015
Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy. Annals of palliative medicine, 2015, Volume: 4, Issue:2 Topics: Aged; Antineoplastic Agents; Blood Glucose; Comorbidity; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Docetaxel; Drug Therapy, Combination; Glucocorticoids; Humans; Hyperglycemia; Male; Monitoring, Physiologic; Ontario; Prednisone; Prostatic Neoplasms; Retrospective Studies; Taxoids; Urinary Bladder Neoplasms; Urogenital Neoplasms	2015
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2. Endocrine-related cancer, 2017, Volume: 24, Issue:1 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Protein 2; Male; Metformin; Prostatic Neoplasms; Protein Serine-Threonine Kinases; RNA, Small Interfering; Taxoids	2017
Glucose intolerance during adjuvant chemotherapy for breast cancer. Journal of the National Cancer Institute, 2009, Apr-01, Volume: 101, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dexamethasone; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Glucose Intolerance; Humans; Hyperglycemia; Hyperinsulinism; Middle Aged; Taxoids	2009
Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. American journal of clinical oncology, 2011, Volume: 34, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Florida; Humans; Hyperglycemia; Kaplan-Meier Estimate; Linear Models; Lymphoma, Non-Hodgkin; Male; Medical Records; Middle Aged; Neoplasm Staging; Prednisone; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Rituximab; Taxoids; Treatment Outcome; Vincristine	2011